Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data Kerri A. SchoedelCarine KollyKasra Shakeri-Nejad Review Open access 13 November 2021 Pages: 1 - 13
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review Nina SchimmersJoost J. BreeksemaRobert A. Schoevers Review 23 November 2021 Pages: 15 - 33
An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder Carolina L. Haass-KofflerRoberta PerciballiRobert M. Swift Original Investigation 03 November 2021 Pages: 35 - 46
Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model Sadia NazirRai Khalid FarooqAneela Javed Original Investigation 14 January 2022 Pages: 47 - 58
Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice Renata L. de OliveiraGuilherme T. VossCristiane Luchese Original Investigation 11 January 2022 Pages: 59 - 81
PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients Jing HuangJingmei XiaoRenrong Wu Original Investigation 14 January 2022 Pages: 83 - 91
Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation Anne S. GibsonPeter J. WestKristen A. Keefe Original Investigation Open access 05 January 2022 Pages: 93 - 104
“Push it!” or “Hold it!”? A comparison of nicotine-avoidance training and nicotine-inhibition training in smokers motivated to quit Alla MachulskaMike RinckJürgen Margraf Original Investigation Open access 11 January 2022 Pages: 105 - 121
5-HT2C receptor perturbation has bidirectional influence over instrumental vigour and restraint Oliver HärmsonLaura L. GrimaMark E. Walton Original Investigation Open access 11 November 2021 Pages: 123 - 140
Effects of OPRM1 and DRD2 on brain structure in drug-naïve adolescents: Genetic and neural vulnerabilities to substance use Giorgia PicciDiana H. FishbeinEmma J. Rose Original Investigation 24 November 2021 Pages: 141 - 152
Behavioral economic analysis of topiramate pharmacotherapy for alcohol: a placebo-controlled investigation of effects on alcohol reinforcing value and delayed reward discounting Kimberly GoodyearRobert Miranda JrJames MacKillop Original Investigation 04 January 2022 Pages: 153 - 161
Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla Beata R. GodlewskaStephen WilliamsPhilip J. Cowen Original Investigation Open access 05 October 2021 Pages: 163 - 171
Investigation of the risk of valproic acid–induced tremor: clinical, neuroimaging, and genetic factors Lili LanXu ZhaoHeidi E. Kirsch Original Investigation 30 October 2021 Pages: 173 - 184
Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depression Edem Ekpenyong EdemCollins-Kevin Chukwudi AnyanwuLinus Anderson Enye Original Investigation 18 November 2021 Pages: 185 - 200
Reducing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on binge-like alcohol drinking in male mice and rats Irene LorraiChase ShankulaGiancarlo Colombo Original Investigation 23 November 2021 Pages: 201 - 213
Sodium butyrate ameliorates the cognitive impairment of Alzheimer’s disease by regulating the metabolism of astrocytes Chen WangDongpeng ZhengLing He Original Investigation 23 November 2021 Pages: 215 - 227
Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines Serge MoudioAshleigh WillisTrevor J. Bushell Original Investigation Open access 09 December 2021 Pages: 229 - 242
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study Le XiaoQian ZhaoGang Wang Original Investigation 06 January 2022 Pages: 243 - 251
Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3 Mina G. NashedShannon WayeJosé N. Nobrega Original Investigation 04 January 2022 Pages: 253 - 266
Targeting PSD95/nNOS by ZL006 alleviates social isolation-induced heightened attack behavior in mice Luqi YangJingyu CuiWen Lu Original Investigation 18 October 2021 Pages: 267 - 276
No antidepressant-like acute effects of bright light on emotional information processing in healthy volunteers Alexander KaltenboeckTereza RuzickovaCatherine J. Harmer Original Investigation Open access 06 November 2021 Pages: 277 - 286
The zebrafish (Danio rerio) anxiety test battery: comparison of behavioral responses in the novel tank diving and light–dark tasks following exposure to anxiogenic and anxiolytic compounds Barbara D. FontanaNancy AlnassarMatthew O. Parker Original Investigation Open access 15 October 2021 Pages: 287 - 296
Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress Caren Nádia Soares de SousaIngridy da Silva MedeirosSilvânia Maria Mendes Vasconcelos Original Investigation 13 January 2022 Pages: 297 - 311
Mitragynine improves cognitive performance in morphine-withdrawn rats Chiek Yi YouZurina HassanFarah Wahida Suhaimi Original Investigation 25 October 2021 Pages: 313 - 325
Association between platelet MAO activity and lifetime drug use in a longitudinal birth cohort study Katre SakalaKairi KasearuJaanus Harro Original Investigation 10 January 2022 Pages: 327 - 337
